Value of GATA3 immunostaining in tumor diagnosis: a review.

Nelson G Ordóñez

Journal: Advances in anatomic pathology 2013;20(5):352-60

PMID: 23939152

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

GATA3 is a member of a group of zinc-finger transcription factors that is involved in cell development and differentiation. Recent studies have shown that, among tumors, GATA3 is commonly expressed in both urothelial tumors and breast epithelial neoplasms. With the exception of salivary gland and parathyroid tumors, GATA3 has been reported to be either absent or only rarely expressed in other epithelial tumors. Owing to its restricted expression in urothelial and breast carcinomas, GATA3 has proved to be a useful immunohistochemical marker for assisting in distinguishing these 2 groups of neoplasms from other malignancies with which they may be confused.

Address: Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. [email protected]

DOI: 10.1097/PAP.0b013e3182a28a68

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/23939152

Subscription / membership required

Full Text Sources:

MeSH Terms: Antibodies, Biomarkers, Tumor, Biopsy, Breast Neoplasms, Carcinoma, Diagnosis, Differential, Female, GATA3 Transcription Factor, Humans, Immunohistochemistry, Male, Neoplasms, Parathyroid Neoplasms, Predictive Value of Tests, Prognosis, Urinary Bladder Neoplasms, Urothelium